| |
| |
|
| Insider
Information: |
Burow Kristina |
| Relationship: |
|
| City: |
Chicago |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
45,023 |
|
|
Indirect Shares
|
43,520,243 |
|
|
| Direct
Value |
$625,752 |
|
|
|
Indirect Value
|
$386,253,788 |
|
|
| Total
Shares |
43,565,266 |
|
|
| Total
Value |
$386,879,540 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
16
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
16
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-16.0
|
0.0
|
| Percentage
Gain/Loss : |
 -18.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2015-08-25 |
0 |
Premium* |
|
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
Director |
2017-08-01 |
0 |
2019-02-22 |
1,865,800 |
Premium* |
|
|
Unity Biotechnology Inc |
UBX |
Director |
2018-05-07 |
0 |
2018-05-07 |
1,795,411 |
Premium* |
|
|
Scholar Rock Holding Corp |
SRRK |
Director |
2023-12-21 |
5,339 |
2023-12-21 |
2,345,711 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
Director |
2019-02-12 |
0 |
2019-02-12 |
4,027,958 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
|
0 |
2019-10-16 |
1,000,000 |
Premium* |
|
|
Beam Therapeutics Inc. |
BEAM |
Director |
2021-06-30 |
12,067 |
2021-06-30 |
2,921,519 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
Director |
2020-09-18 |
0 |
2020-09-18 |
158,734 |
Premium* |
|
|
Neumora Therapeutics, Inc. |
NMRA |
Director, 10% Owner |
2023-12-08 |
27,617 |
2023-12-08 |
28,223,344 |
Premium* |
|
|
Boundless Bio, Inc. |
BOLD |
|
|
0 |
2024-04-02 |
1,181,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCPT |
Receptos, Inc. |
Director |
– • – |
2015-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,669 |
25,746 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Director |
– • – |
2015-06-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,029,822) |
316,908 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Director |
– • – |
2015-08-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(336,540) |
0 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Director |
– • – |
2015-08-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,346) |
7,400 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Director |
– • – |
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,400) |
0 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Director |
– • – |
2017-08-01 |
4 |
A |
$0.00 |
$0 |
I/I |
3,633,068 |
882,493 |
0 |
- |
|
| UBX |
Unity Biotechnology Inc |
Director |
– • – |
2018-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
10,008,634 |
1,682,417 |
0 |
- |
|
| SRRK |
Scholar Rock Holding Corp |
Director |
– • – |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,637,617 |
2,637,617 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
Director |
– • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
8,055,916 |
4,027,958 |
0 |
- |
|
| SNNA |
Sienna Biopharmaceuticals... |
Director |
– • – |
2019-02-22 |
4 |
B |
$2.50 |
$5,414,500 |
I/I |
2,165,800 |
1,865,800 |
2.1 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
444,444 |
|
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-16 |
4 |
B |
$20.00 |
$20,000,000 |
I/I |
1,000,000 |
1,000,000 |
2.1 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
27,222,219 |
15,555,554 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2020-02-10 |
4 |
A |
$0.00 |
$0 |
I/I |
8,243,039 |
4,121,519 |
0 |
- |
|
| MTCR |
Metacrine, Inc. |
Director |
– • – |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,710,503 |
138,734 |
0 |
- |
|
| MTCR |
Metacrine, Inc. |
Director |
– • – |
2020-09-18 |
4 |
B |
$13.00 |
$2,990,000 |
I/I |
230,000 |
158,734 |
2.1 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-03-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
3,921,519 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,012 |
2,012 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-03-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
3,721,519 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,011 |
4,023 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-03-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
3,521,519 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,011 |
6,034 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,011 |
8,045 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-06-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
3,321,519 |
0 |
- |
|
| BEAM |
Beam Therapeutics Inc. |
Director |
– • – |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,011 |
10,056 |
0 |
- |
|
71 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
